SEC Form D · filed January 20, 2022
Equilibre BioPharmaceuticals Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Peter M. Simon · New York, NYDirectorSteven N. Gordon · New York, NYExec · DirectorDavid A. Friedman · New York, NYDirectorPhilip A. Barach · New York, NYDirectorFrancois A. Maisonrouge · New York, NYDirectorSamuel Waksal · New York, NYExec · DirectorJoel Marcus · Pasadena, CADirectorLisa Y. Gokongwei · Grand Cayman, Cayman IslandsDirectorJoost J. Knabben · Luxembourg City, LuxembourgDirectorStefan J. Corthouts · Canach, LuxembourgDirectorPaul P. Bashir · London, United KingdomDirectorPeyman J. Azari · Luxembourg City, LuxembourgExec · DirectorJoel Marcus · New York, NYDirectorDaniel Schulte · Overland Park, KSDirectorJames Maffuccio · Overland Park, KSDirectorBen Fraser · Overland Park, KSDirectorKimberly Melen · Grand Cayman, Cayman IslandsDirectorLouise Groom · Grand Cayman, Cayman IslandsExec · DirectorSamuel Waksal · New York, NYExec · DirectorJoel Marcus · Durham, NCDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗